Autopsy report · NCT03866317

A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus

“Difficulty recruiting participants”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Massachusetts General Hospital

Sponsor type

University, hospital or other

Conditions

Discoid Lupus Erythematosus

Interventions

Secukinumab

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• SiFi vs FNB Local Anesthesia for Hip Fracture Surgeries
  “Difficulties recruiting participants” (99% match in meaning)
• Measurement of Midazolam Levels in Follicular Fluid
  “Difficulty in recruiting participants” (98% match in meaning)
• Sibling-Mediated Intervention on Literacy and Reciprocity for Children With Autism
  “Difficulty in recruiting required participants.” (93% match in meaning)
• PREGBRAIN - Magnetic Stimulation of the Brain in Depressed Pregnant Women
  “Difficult to recruit participants” (92% match in meaning)
• Effects and Consequences for Mother and Child From Treatment for Depression
  “Difficulties in recruiting participants.” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.